ARCHEAN CHEMICAL IND LTD
ACI · General/Diversified · NSE
₹599
Current Market Price
Fair Value (DCF)
₹289
Margin of Safety
-51.9%
Updated 2d ago
YieldIQ Score
33/100
Piotroski F-Score
4/9
Economic Moat
Narrow
Confidence
34%
ROE
—
Debt/Equity
0.15
WACC
11.1%
Market Cap
₹7,400 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
10.5%
Return on capital employed
EV / EBITDA
27.8×
Enterprise multiple
Debt / EBITDA
0.9×
Leverage vs earnings
Interest Coverage
34.5×
EBIT covers interest
Current Ratio
3.50×
Short-term liquidity
Asset Turnover
0.43×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-2.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹599.4
Bear case
₹172.13
MoS -248.2%
Base case
₹288.58
MoS -107.7%
Bull case
₹367.19
MoS -63.2%
Ratio Trends
ACI · last 4 annual periods
ROE
8.7%
ROCE
14.8%
Operating Margin
—
Debt / Equity
0.13×
PE
21.0×
EV / EBITDA
12.0×
Historical Financials
ACI · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹1130 Cr | ₹382 Cr | ₹284 Cr | ₹1039 Cr | -2.7% |
| EBITDA | ₹479 Cr | ₹674 Cr | ₹504 Cr | ₹310 Cr | -13.5% |
| EBIT | — | ₹185 Cr | ₹81.4 Cr | — | -24.0% |
| PAT | ₹188 Cr | ₹137 Cr | ₹57.6 Cr | ₹162 Cr | -4.8% |
| EPS (diluted) | — | ₹11.05 | ₹4.64 | — | -25.1% |
| CFO | ₹315 Cr | ₹496 Cr | ₹379 Cr | ₹176 Cr | -17.6% |
| CapEx | ₹-96.6 Cr | — | — | ₹-264 Cr | — |
| FCF | ₹218 Cr | — | — | ₹-87.3 Cr | — |
| Total Assets | ₹1531 Cr | ₹1755 Cr | ₹2056 Cr | ₹2393 Cr | +16.1% |
| Total Debt | ₹900 Cr | ₹20.7 Cr | ₹0.2 Cr | ₹235 Cr | -36.1% |
| Shareholders' Equity | ₹262 Cr | ₹1431 Cr | ₹1702 Cr | ₹1864 Cr | +92.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ACI vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| GNFC GNFC | — | — | Pending | 7.0% | — |
| INDIAGLYCO INDIAGLYCO | — | — | Pending | 10.2% | — |
| GUJALKALI GUJARAT ALKALIES & CHEM | +25.4% | 41 | Undervalued | -1.1% | — |
| EPIGRAL EPIGRAL LIMITED | +33.1% | 68 | Undervalued | 18.8% | — |
| DEEPAKFERT DEEPAKFERT | — | — | Pending | 14.9% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ACI in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ACI →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ACI →
Compare
Head-to-head with peers
Compare ACI side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ACINow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.